PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Revenue growth of 100.00% while ANO.AX is flat. Bruce Berkowitz would check if a small edge can widen further.
-124.79%
Negative gross profit growth while ANO.AX is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-100.00%
Negative EBIT growth while ANO.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-100.00%
Negative operating income growth while ANO.AX is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-100.00%
Negative net income growth while ANO.AX stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-87.50%
Negative EPS growth while ANO.AX is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-87.50%
Negative diluted EPS growth while ANO.AX is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.60%
Share reduction while ANO.AX is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.60%
Reduced diluted shares while ANO.AX is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
100.00%
OCF growth of 100.00% while ANO.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
99.41%
FCF growth of 99.41% while ANO.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
392.46%
10Y revenue/share CAGR 1.25-1.5x ANO.AX's 263.29%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
53.67%
5Y revenue/share CAGR above 1.5x ANO.AX's 6.29%. David Dodd would look for consistent product or market expansions fueling outperformance.
6.84%
3Y revenue/share CAGR under 50% of ANO.AX's 55.98%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
1439.43%
10Y OCF/share CAGR above 1.5x ANO.AX's 260.38%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
575.55%
5Y OCF/share CAGR above 1.5x ANO.AX's 34.44%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
527.19%
Positive 3Y OCF/share CAGR while ANO.AX is negative. John Neff might see a big short-term edge in operational efficiency.
-1424.35%
Negative 10Y net income/share CAGR while ANO.AX is at 614.96%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-482.04%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-453.40%
Negative 3Y CAGR while ANO.AX is 174.59%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
4455.09%
10Y equity/share CAGR above 1.5x ANO.AX's 915.96%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
136.46%
Below 50% of ANO.AX's 294.63%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
63.14%
3Y equity/share CAGR above 1.5x ANO.AX's 22.63%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while ANO.AX invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.62%
BV/share growth of 1.62% while ANO.AX is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
9.80%
Debt growth of 9.80% while ANO.AX is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-45.13%
We cut SG&A while ANO.AX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.